The company’s independent directors also designated Dr. Daniel C. Stanzione, Ph.D. as Lead Independent Director. Both appointments are effective January 1, 2017.
“During his four and half years as President and CEO, Steve has demonstrated strong leadership, strategic vision, and an ability to drive results and get things done,” said Dr. Stanzione. “The Board carefully considered our governance structure and determined that combining the roles of Chairman and CEO is in the best interest of shareholders to successfully continue to execute Quest Diagnostics’ well-defined strategy.”
Mr. Rusckowski, who joined the company as President, Chief Executive Officer and a director on May 1, 2012, succeeds Dr. Stanzione, who has served as Chairman of the Board during the same period.
To read the full press release, please click here >>
At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.